City

Baltimore (1)

Birmingham (1)

Dallas (1)

Houston (1)

Madison (1)

Memphis (1)

Orange (1)

Phoenix (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 2 (1)

Sponsor

Carl Allen (1)

University of Alabama at Birmingham (1)

Collaborator

Baylor College of Medicine (1)

Genentech, Inc. (1)

North American Consortium for Histiocytosis (1)

Intervention

cobimetinib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

rosai dorfman disease

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Histiocytic Disorder Follow-up Study

Recruiting

Histiocytosis
+5 more

Birmingham, Alabama

University of Alabama at Birmingham

Jun 13, 2023

Langerhan's Cell Histiocytosis, Juvenile Xanthogranuloma, Erdheim-Chester Disease Trial in Memphis, Houston (Cobimetinib)

Recruiting

Langerhan's Cell Histiocytosis
+6 more

Cobimetinib

Phoenix, Arizona
+6 more

Jan 12, 2023